Skip to content

Clinical trials

Carcinoma, Non-Small-Cell Lung trials in Colombia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Country / region: Colombia Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20073
20081
20131
20155
20174
20184
20194
20203
20212
20224
20233
20245
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting17
Active, not recruiting6
Terminated3
Not yet recruiting1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC12
Hoffmann-La Roche6
AstraZeneca5
Novartis Pharmaceuticals5
Bristol-Myers Squibb4
Amgen2
Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo2
EMD Serono Research & Development Institute, Inc.2
Mirati Therapeutics Inc.2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung51
Lung Neoplasms9
Adenocarcinoma of Lung3
Breast Neoplasms3
Neoplasms3
Carcinoma, Hepatocellular2
Ovarian Neoplasms2
Thyroid Neoplasms2
Adenoma, Islet Cell1
Biliary Tract Neoplasms1

Trials

Showing 26 to 50 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.